A clinical trial to find out if PF-06291874 is safe and tolerated by patients with type 2 diabetes mellitus
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses of PF-06291874 Given as Monotherapy to Adults With Type 2 Diabetes Mellitus
Category & Conditions: Diabetes and Metabolic Disorders
Medicine: PF-06291874
ClinicalTrials.gov Identifier (NCT): NCT02175121
Protocol ID: B4801011
PrintDownloadOpen Plain Language Summary Result: Click here